Impact of pharmacological treatments on cognitive and behavioral outcome in the postacute stages of adult traumatic brain injury: A meta-analysis

Journal of Clinical Psychopharmacology

Volumn 31, Issue 6, 2011, Pages 745-757

  Wheaton, Patricia ^a   Mathias, Jane L ^a   Vink, Robert ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

meta analysis; outcome; pharmacological treatment; postacute; traumatic brain injury

Indexed keywords

AMANTADINE; AMITRIPTYLINE; APOMORPHINE; CARBAMAZEPINE; CIPRIMIL; CITALOPRAM; CITICOLINE; DESIPRAMINE; DONEPEZIL; LYPRESSIN; METHYLPHENIDATE; MILNACIPRAN; PHENELZINE; QUETIAPINE; SERTRALINE; UNCLASSIFIED DRUG; ZIPRASIDONE;

AGGRESSION; ANGER; ATTENTION; BEHAVIOR; COGNITION; DATA BASE; DEPRESSION; EFFECT SIZE; GLASGOW COMA SCALE; HAMILTON SCALE; HUMAN; INJURY SEVERITY; MEDICAL LITERATURE; MEDLINE; MEMORY; NEUROPSYCHOLOGICAL TEST; OPEN STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; PSYCHOSIS; PSYCINFO; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCORING SYSTEM; SELF REPORT; SOCIAL PSYCHOLOGY; SYSTEMATIC REVIEW; TRAUMATIC BRAIN INJURY; WECHSLER INTELLIGENCE SCALE; WECHSLER MEMORY SCALE;

ADULT; BEHAVIOR; BRAIN INJURIES; COGNITION DISORDERS; HUMANS; TIME FACTORS; TREATMENT OUTCOME;

EID: 80755140667     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e318235f4ac     Document Type: Review

References (102)

1. Marsh NV, Sleigh JW. Neuropsychiatric functioning after traumatic brain injury. Curr Opin Psychiatry. 2002;15:301-306. (Pubitemid 34430021)
2. Engel DC, Slemmer JE, Vlug AS, et al. Combined effects of mechanical and ischemic injury to cortical cells: secondary ischemia increases damage and decreases effects of neuroprotective agents. Neuropharmacology. 2005;49:985-995. (Pubitemid 41503298)
3. Phillips JP, Devier DJ, Feeney DM. Rehabilitation pharmacology: bridging laboratory work to clinical application. J Head Trauma Rehabil. 2003;18:342-356. (Pubitemid 36899045)
4. Preston JD, O'Neil JH, Talaga MC. Handbook of Clinical Psychopharmacology for Therapists. Oakland, CA: New Harbinger Publications Inc; 2005.
5. Wheaton P, Mathias J, Vink R. Impact of early pharmacological treatment on cognitive and behavioural outcome after traumatic brain injury in adults: a meta-analysis. J Clin Psychopharmacol. 2009;29(5):468-477.
6. Silver JM, McAllister TW, Yudofsky SC. Textbook of Traumatic Brain Injury. Washington, DC: American Psychiatric Publishing Inc; 2005.
7. Pliszka SR. Neuroscience for the Mental Health Clinician. New York, NY: The Guilford Press; 2003.
8. Mysiw WJ, Jackson RD, Corrigan JD. Amitriptyline for post-traumatic agitation. Am J Phys Med Rehabil. 1988;67:29-33.
9. Cassidy JW. Fluoxetine: a new serotonergically active antidepressant. J Head Trauma Rehabil. 1989;4:67-69. (Pubitemid 19144072)
10. Fann JR, Uomoto JM, Katon WJ. Sertraline in the treatment of major depression following mild traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2000;12:226-232. (Pubitemid 30303777)
11. Horsfield SA, Rosse RB, Tomasino V, et al. Fluoxetine's effects on cognitive performance in patients with traumatic brain injury. Int J Psychiatry Med. 2002;32:337-344. (Pubitemid 36539084)
12. Lee H, Kim S-W, Kim J-M, et al. Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury. Hum Psychopharmacol. 2005;20:97-104. (Pubitemid 40372485)
13. Chandler MC, Barnhill JL, Gualtieri CT. Amantadine for the agitated head-injury patient. Brain Inj. 1988;2:309-311.
14. Gualtieri CT, Evans RW. Stimulant treatment for the neurobehavioural sequelae of traumatic brain injury. Brain Inj. 1988;2:273-290.
15. Nickels JL, Schneider WN, Dombovy ML, et al. Clinical use of amantadine in brain injury rehabilitation. Brain Inj. 1994;8:709-718. (Pubitemid 24353193)
16. Karli DC, Burke DT, Kim HJ, et al. Effects of dopaminergic combination therapy for frontal lobe dysfunction in traumatic brain injury rehabilitation. Brain Inj. 1999;13:63-68. (Pubitemid 29043322)
17. Masanic CA, Bayley MT, vanReekum R, et al. Open-label study of donepezil in traumatic brain injury. Arch Phys Med Rehabil. 2001;82:896-901. (Pubitemid 32619812)
18. Azouvi P, Jokic C, Attal N, et al. Carbamazepine in agitation and aggressive behaviour following severe closed-head injury: results of an open trial. Brain Inj. 1999;13:797-804. (Pubitemid 29488206)
19. Kim E, Humaran TJ. Divalproex in the management of neuropsychiatric complications of remote acquired brain injury. J Neuropsychiatry Clin Neurosci. 2002;14:202-205. (Pubitemid 34556531)
20. Beresford TP, Arciniegas D, Clapp L, et al. Reduction of affective lability and alcohol use following traumatic brain injury: a clinical pilot study of anti-convulsant medications. Brain Inj. 2005;19:309-313. (Pubitemid 40260103)
21. Kaelin DL, Cigu DX, Matthies B. Methylphenidate effect on attention deficit in the acutely brain-injured adult. Arch Phys Med Rehabil. 1996;77:6-9. (Pubitemid 26017483)
22. Whyte J, Hart T, Schuster K, et al. Effects of methylphenidate on attentional function after traumatic brain injury. Am J Phys Med Rehabil. 1997;76:440-450. (Pubitemid 128721462)
23. Meythaler JM, Brunner RC, Johnson A, et al. Amantadine to improve neurorecovery in traumatic brain injuryYassociated diffuse axonal injury: a pilot double-blind randomized trial. J Head Trauma Rehabil. 2002;17:300-313. (Pubitemid 34809595)
24. Plenger PM, Dixon CE, Castillo RM, et al. Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study. Arch Phys Med Rehabil. 1996;77:536-540. (Pubitemid 26180922)
25. Jackson RD, Corrigan JD, Arnett MA. Amitriptyline for agitation in head injury. Arch Phys Med Rehabil. 1985;66:180-181. (Pubitemid 15138386)
26. Fann JR, Uomoto JM, Katon WJ. Cognitive improvement with treatment of depression following mild traumatic brain injury. Psychosomatics. 2001;42:48-54. (Pubitemid 32062215)
27. Saniova B, Drobny M, Kneslova L, et al. The outcome of patients with severe head injuries treated with amantadine sulphate. J Neural Transm. 2004;111:511-514. (Pubitemid 38478918)
28. Kraus JF, Chu LD. Epidemiology. In: Silver JM, McAllister TW, Yudofsky SC, eds. Textbook of Traumatic Brain Injury. Washington, DC: American Psychiatric Publishing Inc; 2005:3-26.
29. Levin HS, Peters BH, Kalisky Z, et al. Effects of oral physostigmine and lecithin on memory and attention in closed head-injured patients. Cent Nerv Syst Trauma. 1986;3:333-342. (Pubitemid 17055012)
30. Kaye NS, Townsend JB, Ivins R. An open-label trial of donepezil (Aricept) in the treatment of persons with mild traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2003;15:383-384.
31. Zhang L, Plotkin RC, Wang G, et al. Cholinergic augmentation with donepezil enhances recovery in short-term memory and sustained attention after traumatic brain injury. Arch Phys Med Rehabil. 2004;85:1050-1055. (Pubitemid 38962359)
32. Khateb A, Ammann J, Annoni J-M, et al. Cognition-enhancing effects of donepezil in traumatic brain injury. Eur Neurol. 2005;54:39-45. (Pubitemid 41328733)
33. Speech TJ, Rao SM, Osmon DC, et al. A double-blind controlled study of methylphenidate treatment in closed head injury. Brain Inj. 1993;7:333-338. (Pubitemid 23218380)
34. Leon-Carrion J, Dominguez-Roldan JM, Murillo-Cabezas F, et al. The role of citicholine in neuropsychological training after traumatic brain injury. Neurorehabilitation. 2000;14:33-40. (Pubitemid 30316073)
35. Dikmen SS, Machamer MA, Winn MD, et al. Neuropsychological effects of valproate in traumatic brain injury. Neurology. 2000;54(4):895-902. (Pubitemid 30111349)
36. Filipova M, Jung M, Krejcova H. Clinical efficacy of 1-desamino-8-D- arginine-vasopressin (DDAVP) in short-term recovery from minor head injury. Hum Psychopharmacol. 1989;4:47-50. (Pubitemid 19090738)
37. Eames P, Wood RL. Lysine vasopressin in post-traumatic memory disorders: an uncontrolled pilot study. Brain Inj. 1999;13:255-260. (Pubitemid 29176769)
38. Alvarez XA, Sampedro C, Perez P, et al. Positive effects of cerebrolysin on electroencephalogram slowing, cognition and clinical outcome in patients with postacute traumatic brain injury: an exploratory study. Int Clin Psychopharmacol. 2003;18:271-272.
39. Jenkins JS, Mather HM, Coughlan AK, et al. Desmopressin and desglycinamide vasopressin in post-traumatic amnesia. Lancet. 1981;1:39. (Pubitemid 11200343)
40. Reichert WH, Blass JP. A placebo-controlled trial shows no effect of vasopressin on recovery from closed head injury. Ann Neurol. 1982;12:390-392. (Pubitemid 12024358)
41. Fewtrell WD, House AO, Jamie PF, et al. Effects of vasopressin on memory and new learning in a brain-injured population. Psychol Med. 1982;12:423-425. (Pubitemid 12060567)
42. Tilley A. An Introduction to Psychological Research and Statistics. Brisbane, Australia: Pineapple Press; 1996.
43. Satz P, Zaucha K, Forney DL, et al. Neuropsychological, psychosocial and vocational correlates of the Glasgow Outcome Scale at 6 months post-injury: a study of moderate to severe traumatic brain injury patients. Brain Inj. 1998;12:555-567. (Pubitemid 28302004)
44. Lepeintre J-F, D'Arbigny P, Mathe J-F, et al. Neuroprotective effect of gacyclidine: a multicenter double-blind pilot trial in patients with acute traumatic brain injury. Neurochirurgie. 2004;50:83-95. (Pubitemid 38808040)
45. Saran AS. Depression after minor closed head injury: role of dexamethasone suppression test and antidepressants. J Clin Psychiatry. 1985;46:335-338. (Pubitemid 15005098)
46. Cardenas DD, McLean A, Farrell-Roberts L, et al. Oral physostigmine and impaired memory in adults with brain injury. Brain Inj. 1994;8:579-587. (Pubitemid 24293689)
47. Morey CE, Cilo M, Berry J, et al. The effect of Aricept in persons with persistent memory disorder following traumatic brain injury: a pilot study. Brain Inj. 2003;17(9):809-815. (Pubitemid 36763707)
48. Whyte J, Hart T, Vaccaro M, et al. Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional randomized, controlled trial. Am J Phys Med Rehabil. 2004;83:401-420. (Pubitemid 38658128)
49. Whyte J, Vaccaro M, Grieb-Neff P, et al. The effects of bromocriptine on attention deficits after traumatic brain injury: a placebo-controlled pilot study. Am J Phys Med Rehabil. 2008;87:85-99.
50. Morris SB, DeShon RP. Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs. Psychol Methods. 2002;7:105-125.
51. Dallal GE. The Computer-Aided Analysis of Crossover Studies. Available at: http://www.tufts.edu/~gdallal/crossovr.htm. 2000. Accessed October 20, 2006.
52. Garcia R, Benet M, Arnau C, et al. Efficiency of the cross-over design: an empirical estimation. Stat Med. 2004;23:3773-3780. (Pubitemid 40074076)
53. Schulz, KF, Chalmers, I, Hayes, RJ, et al. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273(5):408-412.
54. Hrobjartsson, A, Gotzsche, PC. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N Engl J Med. 2001;344(21):1594-1602. (Pubitemid 32479913)
55. Wroblewski BA, Joseph AB, Cornblatt RR. Antidepressant pharmacotherapy and the treatment of depression in patients with severe traumatic brain injury: a controlled, prospective study. J Clin Psychiatry. 1996;57:582-587. (Pubitemid 27056901)
56. Willmott C, Ponsford, J. Efficacy of methylphenidate in the rehabilitation of attention following traumatic brain injury: a randomised, crossover, double blind, placebo controlled inpatient trial. J Neurol Neurosurg Psychiatry. 2009;80:552-557.
57. Saran A. Antidepressants not effective in headache associated with minor closed head injury. Int J Psychiatry Med. 1988;18:75-83.
58. Zakzanis KK. Statistics to tell the truth, the whole truth, and nothing but the truth: formulae, illustrative numerical examples, and heuristic interpretation of effect size analyses for neuropsychological researchers. Arch Clin Neuropsychol. 2001;16:653-667. (Pubitemid 32799136)
59. Lucassen PLBJ, Assendelft WJJ, Gubbels JW, et al. Effectiveness of treatments for infantile colic: systematic review. Br Med J. 1998;316:1563-1569. (Pubitemid 28234096)
60. Cohen J. Statistical Power Analysis for the Behavioural Sciences. New York, NY: Academic Press; 1977.
61. Cohen J. Quantitative methods in psychology: a power primer. Psychol Bull. 1992;112:155-159.
62. Lipsey MW, Wilson DB. Practical Meta-Analysis. Thousand Oaks, CA: SAGE Publications; 2001.
63. Hunter JE, Schmidt FL. Methods of Meta-analysis: Correcting Error and Bias in Research Findings. Thousand Oaks, CA: Sage Publications Inc; 2004.
64. Rothstein HR, Sutton AJ, Borenstein M. Publication Bias in Meta-analysis: Prevention, Assessment and Adjustments. England, UK: John Wiley & Sons Ltd; 2005.
65. Zakzanis KK, Leach L, Kaplan E. Neuropsychological Differential Diagnosis. Lisse, the Netherlands: Swets & Zeitlinger; 1999.
66. Rosenthal R. Writing meta-analytic reviews. Psychol Bull. 1995;118:183-192.
67. Dinan TG, Mobayed M. Treatment resistance of depression after head injury: a preliminary study of amitriptyline response. Acta Psychiatr Scand. 1992;85:292-294.
68. Perino C, Rago R, Cicolin A, et al. Mood and behavioural disorders following traumatic brain injury: clinical evaluation and pharmacological management. Brain Inj. 2001;15:139-148. (Pubitemid 32149347)
69. Mooney GF, Haas LJ. Effect of methylphenidate on brain injuryYrelated anger. Arch Phys Med Rehabil. 1993;74:153-160. (Pubitemid 23059300)
70. Kim Y-H, Ko M-H, Na S-Y, et al. Effects of single-dose methylphenidate on cognitive performance in patients with traumatic brain injury: a double-blind placebo-controlled study. Clin Rehabil. 2006;20:24-30. (Pubitemid 43246329)
71. Fridman EA, Krimchansky BZ, Bonetto M, et al. Continuous subcutaneous apomorphine for severe disorders of consciousness after traumatic brain injury. Brain Inj. 2010;24(4):636-641.
72. Kim E, Bijlani M. A pilot study of quetiapine treatment of aggression due to traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2006;18:547-549. (Pubitemid 44713895)
73. Noe E, Ferri J, Trenor C, et al. Efficacy of ziprasidone in controlling agitation during post-traumatic amnesia. Behav Neurol. 2007;18:7-11. (Pubitemid 46333650)
74. Kim YW, Kim DY, Shin J-C, et al. The changes of cortical metabolism associated with the clinical response to donepezil therapy in traumatic brain injury. Clin Neuropharm. 2009;32:63-68.
75. Kraus MF, Smith GS, Butters M, et al. Effects of the dopaminergic agent and NMDA receptor antagonist amantadine on cognitive function, cerebral glucose metabolism and D2 receptor availability in chronic traumatic brain injury: a study using positron emission tomography (PET). Brain Inj. 2005;19:471-479. (Pubitemid 40852596)
76. Kanetani K, Kimura M, Endo S. Therapeutic effects of milnacipran (serotonin noradrenalin reuptake inhibitor) on depression following mild and moderate traumatic brain injury. J Nippon Med Sch. 2003;70:313-320. (Pubitemid 37071315)
77. Alvarez XA, Sampedro C, Figueroa J, et al. Reductions in qEEG slowing over 1 year and after treatment with cerebrolysin in patients with moderate-severe traumatic brain injury. J Neural Transm. 2008;115:683-692.
78. Walker W, Seel R, Gibellato M, et al. The effects of donepezil on traumatic brain injury acute rehabilitation. Brain Inj. 2004;18(8):739-750. (Pubitemid 38961287)
79. Wagner AK, Kline AE, Ren D et al. Gender associations with chronic methylphenidate treatment and behavioural performance following experimental traumatic brain injury. Behav Brain Res. 2007;181:200-209. (Pubitemid 46898657)
80. Kikuchi K, Nishino K, Ohyu H. Increasing CNS norepinephrine levels by the precursor L-DOPS facilitate beam-walking recovery after sensorimotor cortex ablation in rats. Brain Res. 2000;860:130-135. (Pubitemid 30155845)
81. Chudasama Y, Nathwani F, Robbins TW. D-Amphetamine remediates attentional performance in rats with dorsal prefrontal lesions. Behav Brain Res. 2005;158:97-107. (Pubitemid 40174715)
82. Granacher RP. Traumatic Brain Injury: Methods for Clinical and Forensic Neuropsychiatric Assessment. Boca Raton, FL: CRC Press; 2008.
83. McAllister TW, Flashman LA, Sparling MB, et al. Working memory deficits after traumatic brain injury: catecholaminergic mechanisms and prospects for treatmentVa review. Brain Inj. 2004;18:331-350. (Pubitemid 38232727)
84. Gualtieri CT. Brain Injury and Mental Retardation: Psychopharmacology and Neuropsychiatry. Philadelphia, PA: Lippincott, Williams & Wilkins; 2002:75.
85. High WM, Sander AM, Struchen MA, et al. Rehabilitation for Traumatic Brain Injury. Oxford, NY: Oxford University Press; 2005.
86. Ashley MJ. Traumatic Brain Injury: Rehabilitative Treatment and Case Management. Boca Raton, FL: CRC Press; 2004.
87. Gordon WA, Haddad L, Brown M, et al. The sensitivity and specificity of self-reported symptoms in individuals with traumatic brain injury. Brain Inj. 2000;14:21-33. (Pubitemid 30040153)
88. Green A, Felmingham K, Baguley IJ, et al. The clinical utility of the Beck Depression Inventory after traumatic brain injury. Brain Inj. 2001;15:1021-1028. (Pubitemid 33120960)
89. Rapoport MJ, McCullagh S, Streiner D, et al. The clinical significance of major depression following mild traumatic brain injury. Psychosomatics. 2003;44:31-37. (Pubitemid 36050570)
90. Rapoport MJ, McCullagh S, Shammi P, et al. Cognitive impairment associated with major depression following mild and moderate traumatic brain injury. J Neuropsychiatry Clin Neurosci. 2005;17:61-65. (Pubitemid 40283771)
91. Lezak MD, Howieson DB, Loring DW. Neuropsychological Assessment. Oxford, NY: Oxford University Press; 2004.
92. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;5:561-571.
93. Hornstein A, Lennihan L, Seliger G, et al. Amphetamine in recovery from brain injury. Brain Inj. 1996;10:145-148. (Pubitemid 26115895)
94. Shiller AD, Burke DT, Kim HJ, et al. Treatment with amantadine potentiated motor learning in a patient with traumatic brain injury of 15 years' duration. Brain Inj. 1999;13:715-721. (Pubitemid 29435855)
95. New Zealand Guidelines Group. Traumatic Brain Injury: Diagnosis, Acute Management and Rehabilitation, Evidence-Based Best Practice Guideline. Wellington, New Zealand: New Zealand Guidelines Group; 2006.
96. Warden DL, Gordon B, McAllister TW, et al. Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury. J Neurotrauma. 2006;23(10):1468-1501. (Pubitemid 46489606)
97. Waldron-Perrine B, Hanks RA, Perrine SA. Pharmacotherapy for postacute traumatic brain injury: a literature review for guidance in psychological practice. Rehabil Psychol. 2008;53(4):426-444.
98. Chew E, Zafonte RD. Pharmacological management of neurobehavioral disorders following traumatic brain injuryVa state-of-the-art review. J Rehabil Res Dev. 2009;46(6):851-878.
99. Fleminger S, Greenwood RRJ, Oliver DL. Pharmacological management for agitation and aggression in people with acquired brain injury. Cochrane Database Syst Rev. 2006;4:CD003299.
100. Dworkin RJ. Hidden bias in the use of archival data. Eval Health Prof. 1987;10:173-185. (Pubitemid 17132011)
101. Gearing RE, Mian IA, Barber J, et al. A methodology for conducting retrospective chart review research in child and adolescent psychiatry. J Can Acad Child Adolesc Psychiatry. 2006;13:126-134. (Pubitemid 44541019)
102. Rosenthal R. The "file drawer problem" and tolerance for null results. Psychol Bull. 1979;86(3):638-641.